Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Alpha-1b in Metastatic Clear Cell Renal Carcinoma
NCT00278174Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Feb 2005
- Primary completion
- Apr 2007
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant human interferon alpha-1b in clear cell renal cell carcinoma (ccRCC), sponsored by Case Comprehensive Cancer Center. Started Feb 2005; status: completed.
02
Drugs
recombinant human interferon alpha-1b
03
Conditions
clear cell renal cell carcinoma (ccRCC)
Beyond the preview
Go deeper on NCT00278174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00278174.